Sales rise 8.56% to Rs 2556.50 crore
Net profit of Ipca Laboratories rose 23.13% to Rs 282.57 crore in the quarter ended September 2025 as against Rs 229.48 crore during the previous quarter ended September 2024. Sales rose 8.56% to Rs 2556.50 crore in the quarter ended September 2025 as against Rs 2354.90 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales2556.502354.90 9 OPM %21.3218.75 -PBDT553.17445.18 24 PBT449.84344.83 30 NP282.57229.48 23Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
